Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Blueprint Medicines Corp shares valued at $475,000 were sold by Landsittel Michael on Mar 28 ’24. At $95.00 per share, Landsittel Michael sold 5,000 shares. The insider’s holdings dropped to 47,286 shares worth approximately $4.2 million following the completion of this transaction.
Also, Albers Jeffrey W. sold 25,073 shares, netting a total of over 2,188,264 in proceeds. Following the sale of shares at $87.28 each, the insider now holds 176,050 shares.
Before that, Landsittel Michael had sold 13,734 shares from its account. In a trade valued at $1,205,606, the CHIEF FINANCIAL OFFICER traded Blueprint Medicines Corp shares for $87.78 each. Upon closing the transaction, the insider’s holdings decreased to 13,734 shares, worth approximately $4.2 million.
As published in a research note from Oppenheimer on October 27, 2023, Blueprint Medicines Corp [BPMC] has been rated up from a Perform to an Outperform and the price target has been revised to $85. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in late August. As of July 31, 2023, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for BPMC. Earlier on June 05, 2023, SVB Securities downgraded its rating. Their new recommendation was “an Underperform” for BPMC stock which previously was a “a Market perform”.
Analyzing BPMC Stock Performance
During the last five days, there has been a drop of approximately -3.63%. Over the course of the year, Blueprint Medicines Corp shares have dropped approximately -3.62%. Shares of the company reached a 52-week high of $101.00 on 02/28/24 and a 52-week low of $72.24 on 02/14/24. A 50-day SMA is recorded $88.78, while a 200-day SMA reached $69.41. Nevertheless, trading volume fell to 0.73 million shares from 0.41 million shares the previous day.
Support And Resistance Levels for Blueprint Medicines Corp (BPMC)
According to the 24-hour chart, there is a support level at 86.39, which, if violated, would cause prices to drop to 83.87. In the upper region, resistance lies at 91.59. The next price resistance is at 94.27. RSI (Relative Strength Index) is 48.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.55, which suggests the price will decrease in the coming days. Percent R is at 63.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
